other material
confidence high
sentiment neutral
materiality 0.25
Sunshine Biopharma cuts Series B warrant exercise price to $1.2046
Sunshine Biopharma Inc.
- As of September 11, 2026, Sunshine Biopharma reduced its Series B Warrant exercise price to $1.2046.
- Reduction stems from recent common-stock sales under the company's at-the-market offering.
- The exercise price remains subject to further adjustment per Series B Warrant terms.